Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-13

Clinical Trial Update: Quetiapine and Concerta in the Treatment for ADHD and Aggressive Behavior. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating quetiapine in combination with Concerta for attention-deficit/hyperactivity disorder with aggressive behavior; the study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CONCERTA (METHYLPHENIDATE HYDROCHLORIDE)
  • SEROQUEL (QUETIAPINE)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 2 | Status: COMPLETED | Results posted: 2015-05-13